2018 Heart Valve Summit | Mitral Valve Repair Center Skip to main content
ACC Logo

The American College of Cardiology and the American Association for Thoracic Surgery are partnering to disseminate the latest advances in valvular heart disease (VHD). Renowned faculty will analyze current controversies, and provide insight into the possibilities of valvular care in the future. With an emphasis on practical decision-making, the Heart Valve Summitprovides cutting-edge findings; real-world implications; and through a case-based curriculum offers practical guidance on common, yet challenging scenarios. The course empowers the Heart Team by promoting best practices from colleagues in other specialties and demonstrating the collective expertise of the VHD care team in delivering high-quality patient care.

Valvular heart disease (VHD) affects more than 5 million adults in the United States. The management of VHD has been transformed during the past decade by advanced imaging technology and the emergence and rapid expansion of Transcatheter-based treatment options. Concurrently, a cadre of general clinical cardiologists, interventional cardiologists, non-invasive cardiac imagers, cardiothoracic surgeons, and other healthcare professionals have acquired deep expertise in valvular care and collectively represent an emerging subspecialty. The care of patients with advanced valvular disease often requires a multidisciplinary collaboration to engage in complex decision-making and treatment. In this time of rapid evolution, all members of the heart team need ongoing and frequent education to stay abreast of the accruing evidence and to learn from experts who are pioneering new techniques and can offer deep insight into contemporary clinical trials and treatment dilemmas.

Thursday, October 11

7:00 am  SESSION I: CHALLENGES IN MITRAL CARE - Moderators: Drs. Adams and Bonow

7:30 am  Case Challenges: The Mitral Clinic - Dr. Adams, Presenters: Drs. Bolling, Martin, McCarthy, Nishimura and O’Gara

9:50 am  SESSION II: Latest Science In Mitral Care: The COAPT Trial, Edge to Edge Repair and Surgical IMR Strategy - Moderators: Drs. Adams and Herrmann

Friday, October 12

7:30 am  SESSION V: VALVE ENDOCARDITIS - Moderators: Drs. Anyanwu and O’Gara

7:55 am  Valve Reconstruction in Mitral Endocarditis - Dr. Adams

8:50 am Case Challenges in Valve Endocarditis - Presenters: Drs. Anyanwu, Martin and Thomas

11:05 am  Surgical Management of Tricuspid Valve Disease: Current and Future Options - Dr. Anyanwu

12:30 pm  Featured Lunch Symposium: Volume Standards and Regionalization of Care for Surgery and Transcatheter Valve Interventions Dr. Carroll - Panel: Drs. Acker, Adams, Bolling, Leon and Lindman

2:10 pm  Case Challenges – New Mitral and Tricuspid Therapies - Presenters: Drs. Anyanwu, Carroll, Herrmann, O’Gara and Whisenant

3:00 pm  SESSION IX: Aortic Valve Disease Potpourri - Moderators: Drs. Coselli and Leon Panel: Drs. Anyanwu, Bonow, David, McCarthy and O’Gara

4:25 pm  Case Challenges in Aortic Valve Disease - Presenters: Drs. Adams, Carroll, Coselli, Herrmann and Moon

Saturday, October 13

7:30 am  SESSION X: Tough Choices in Valve Care: Would you rather…? - Moderators: Drs. Adams and Anyanwu

8:50 am  Surgery or Active Surveillance Severe TR After Mitral Valve Surgery? - Dr. Adams

9:50 am  Aspirin or Warfarin Therapy After Biological Valve Replacement? - Dr. Anyanwu 

Page Created: August 31, 2018 Last Updated: December 07, 2018